ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.00
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EDT - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $90.82 million as of September 3, 2026. Its market cap has increased by 62.46% in one year.
Market Cap
90.82M
Enterprise Value
94.41M
1-Year Change
62.46%
Ranking
Category
Stock Price
$10.00
ChartMarket Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $90.82M, an increase of 4,459.34%. That is a compound annual growth rate of 11.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 90.82M | 63.25% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 93.85M |
| Kalaris Therapeutics | 93.79M |
| PMV Pharmaceuticals | 93.64M |
| Pelthos Therapeutics | 93.26M |
| Verrica Pharmaceuticals | 92.08M |
| Fortress Biotech | 90.38M |
| Rallybio | 89.61M |
| Aldeyra Therapeutics | 89.28M |